Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13923800 | 1.00 | KMT2A (0.50) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL5861107 | 1.00 | KMT2A (0.50) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL11948863 | 1.00 | KMT2A (0.50) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL6054594 | 0.94 | CYP1A2 (0.51) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL6248687 | 0.94 | CYP1A2 (0.51) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL6248685 | 0.94 | CYP1A2 (0.51) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL6054595 | 0.94 | CYP1A2 (0.51) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL10076671 | 0.93 | CYP1A2 (0.46) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL17975194 | 0.86 | CYP1A2 (0.49) | KMT2ACYP1A2TDP1ALDH1A1CNR2 | |
| SCHEMBL12117017 | 0.86 | CYP1A2 (0.49) | KMT2ACYP1A2TDP1ALDH1A1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250153157-A1 | PALLADIUM PRECATALYST EMBODIMENTS FOR ENANTIOSELECTIVE CHEMICAL REACTIONS AND METHODS OF MAKING AND USING THE SAME | UVIC IND PARTNERSHIPS INC (CA) | 2025-05-15 | — | — | US | disclosed |
| EP-4479411-A1 | PALLADIUM PRECATALYST EMBODIMENTS FOR ENANTIOSELECTIVE CHEMICAL REACTIONS AND METHODS OF MAKING AND USING THE SAME | UVIC Industry Partnerships Inc. (CA) | 2024-12-25 | — | — | EP | disclosed |
| WO-2023156972-A1 | PALLADIUM PRECATALYST EMBODIMENTS FOR ENANTIOSELECTIVE CHEMICAL REACTIONS AND METHODS OF MAKING AND USING THE SAME | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2023-08-24 | — | — | WO | disclosed |
| US-10565015-B2 | Spiroketal-based C2-symmetric scaffold for asymmetric catalysis | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-02-18 | — | — | US | disclosed |
| US-20190084995-A1 | Spiroketal-Based C2-Symmetric Scaffold For Asymmetric Catalysis | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-03-21 | — | — | US | disclosed |
| US-20160222041-A1 | BIARYL LIGANDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2016-08-04 | — | — | US | disclosed |
| US-7713900-B2 | Chiral tertiary aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2010-05-11 | — | — | US | disclosed |
| US-7674900-B2 | Chiral tertiary aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2010-03-09 | — | — | US | disclosed |
| US-20080255356-A1 | CHIRAL TERTIARY AMINOALKYLNAPHTHOLS | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2008-10-16 | — | — | US | disclosed |
| US-20070225497-A1 | Chiral Tertiary Aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2007-09-27 | — | — | US | disclosed |
| US-20070225497-A1 | Chiral Tertiary Aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2007-09-27 | — | — | US | disclosed |
| US-7009065-B2 | Ferrocenyl ligands and the use thereof in catalysis | DEGUSSA AG (DE) | 2006-03-07 | — | — | US | disclosed |
| US-20050234253-A1 | Ferrocenyl ligands and the use thereof in catalysis | DEGUSSA AG (DE) | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10565015-B2 | Spiroketal-based C2-symmetric scaffold for asymmetric catalysis | PKD2, OPA1, PKD1 | KMT2A 3015/4885CYP1A2 226/4885TDP1 4330/4885 |
| US-20070225497-A1 | Chiral Tertiary Aminoalkylnaphthols | DDT, AGPS, HRH3 | KMT2A 1710/4885CYP1A2 58/4885TDP1 3641/4885 |
| US-20080255356-A1 | CHIRAL TERTIARY AMINOALKYLNAPHTHOLS | DDT, AGPS, HRH3 | KMT2A 1710/4885CYP1A2 58/4885TDP1 3641/4885 |
| US-20190084995-A1 | Spiroketal-Based C2-Symmetric Scaffold For Asymmetric Catalysis | PKD2, OPA1, PKD1 | KMT2A 3015/4885CYP1A2 226/4885TDP1 4330/4885 |
| US-20050234253-A1 | Ferrocenyl ligands and the use thereof in catalysis | FECH, SLC40A1, FDPS | KMT2A 3596/4885CYP1A2 661/4885TDP1 2289/4885 |
| US-20160222041-A1 | BIARYL LIGANDS | BID, BLVRB, ABCG2 | KMT2A 1790/4885CYP1A2 16/4885TDP1 1648/4885 |
| US-20250153157-A1 | PALLADIUM PRECATALYST EMBODIMENTS FOR ENANTIOSELECTIVE CHEMICAL REACTIONS AND METHODS OF MAKING AND USING THE SAME | PPOX, PDCD1, DDT | KMT2A 430/4885CYP1A2 1106/4885TDP1 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.